Client’s Testimonial:
“I know that my case was not a strong one. Thank you for all you hard work on my case.”
On January 15th, 2016, we received another EB-1B approval for a Senior Scientist in the Field of Pharmaceutical Chemistry (Approval Notice).
General Field: Pharmaceutical Chemistry
Position at the Time of Case Filing: Senior Scientist
Country of Origin: China
Service Center: Texas Service Center (TSC)
State of Residence at the Time of Filing: Kansas
Approval Notice Date: January 15th, 2016
Processing Time: 18 days (Premium Processing requested)
Case Summary:
North America Immigration Law Group recently had the pleasure of working with a senior scientist from China who wanted us to file an EB-1B (Outstanding Professors and Researchers) petition on her behalf. Our client’s employer, a university spin-out company, served as her beneficiary.
Our client has a Master of Science in Analytical Chemistry and a Doctor of Philosophy in Pharmaceutics and Drug Delivery. She decided to file her EB-1B petition under Premium Processing and received an approval from the USCIS just 18 days after we filed her case.
In our well-thought-out petition packet, we included various aspects of her professional portfolio: the 44 citations of her work, her 9 published papers, and the 36 times that she conducted peer reviews for nine scientific journals. Our EB-1B petition also included a summary of our client’s research on improving the targeted delivery of drugs and developing improved imaging contrast agents for cancer detection. North America Immigration Law Groupdemonstrated that our client’s research not only saves lives, but also advances the United States’ medical and pharmaceutical industries.
To strengthen our client’s case, we helped her request recommendation letters from expert pharmaceutical chemists. We included these letters in the petition packet. One expert wrote, “[Client’s] documented discoveries are highly significant to the analytical and pharmaceutical chemistry communities, as her research is fundamental for developing improved extraction processes of molecules that are crucial to treatments of widespread diseases as chronic bronchitis, sexually transmitted infections, and cancerous mutations.”
The approval of this I-140 is another example of our firm’s dedication to helping our clients obtain their green cards.
We are pleased to announce that North America Immigration Law Group has so far received over 3,500 EB-1A,EB-1B and EB-2 NIW approval notices. In 2014 and 2015, the approval rate is 98.22% for cases using our "Approval or Refund®" (money back guarantee) service and 96.95% for all kinds of services.
For NIW cases, the approval rate is 99.18% for cases using our "Approval or Refund®" (money back guarantee) service and the overall approval rate for all NIW cases is 98.47%.
For EB1A cases, the approval rate is 97.25% for "Approval or Refund®" (money back guarantee) service and the overall approval rate for all EB1A cases is 95.27%.
We are one of the leading U.S. immigration law firms providing the most comprehensive services for EB-1/NIWpetition with a large volume of approval cases and high approval rate.
Our staff keeps close track of the latest immigration trends and regulations of USCIS (U.S. Citizenship and Immigration Services), decisions of AAO (Administrative Appeal Office) and judicial review opinions. The massive collected materials contribute to the most convincing arguments and winning strategies of our firm for EB1A,EB1B, and NIW petitions.
If you are interested in filing the green card, please send your CV to law@wegreened.com for our free evaluation. Our attorneys will email you back with the evaluation result within 24 hours.
Approval Notices: http://www.wegreened.com/eb1_niw_approvals
Success Stories: http://blog.wegreened.com/
Website: www.wegreened.com
Free evaluation email: law@wegreened.com
Tel: 888.666.0969 (Toll Free)
To see more clients’ testimonials and approvals, please refer to:
To Learn More About Your Options CLICK HERE
Copyright © North America Immigration Law Group – WeGreened.com, All Rights Reserved.